'Triple negative breast cancer' presentation slideshows

PARP Inhibitors: Usurping DNA repair to target cancer

PARP Inhibitors: Usurping DNA repair to target cancer. Lee Schwartzberg MD, FACP Chief Medical Officer The West Clinic. Question 1. DNA repair mechanisms are important in Cancer cells only Both cancer and normal eukaryotic cells

2.21k views • 39 slides

PARP Inhibitors: Usurping DNA repair to target cancer

PARP Inhibitors: Usurping DNA repair to target cancer. Lee Schwartzberg MD, FACP Chief Medical Officer The West Clinic. Question 1. DNA repair mechanisms are important in Cancer cells only Both cancer and normal eukaryotic cells

782 views • 39 slides

Overview of Cancer Genetics

Overview of Cancer Genetics. The Role of Cancer Genetics in Precision Medicine April 17, 2018 / May 1, 2018. Vanessa Manso / Matthew Share, MS Licensed / Certified Genetic Counselor William G. Rohrer Cancer Genetics Program. Objectives.

467 views • 37 slides

Triple Negative Breast Cancer

Triple Negative Breast Cancer. Lazzaro Repetto ASL 1 Imperiese Ospedale G. Borea - Sanremo. Clinical Aspects and Biology of TNBC. TIL. necrosis. Cell sheets. TIL. Pushing tumor. ER 0. Atypia & mitosis. ER 0. ER+ in normal tissue. EGFR. W Fooulkes , NEJM 2010. CK-5.

914 views • 34 slides

DeepPhe

University of Pittsburgh. Vanderbilt University. Dana Farber Cancer Institute. BCH. Harry Hochheiser Olga Medvedeva Zhou Yuan Mike Davis Past: Rebecca Jacobson, MPI Girish Chavan Eugene Tseytlin Melissa Castine Adrian Lee John Kirkwood Francesmary Modugno.

184 views • 18 slides

Understanding and Treating Triple-Negative Breast Cancer

Understanding and Treating Triple-Negative Breast Cancer. Elshami M. Elamin, MD Medical Oncologist Central Care Cancer Center www.cccancer.com Wichita, KS - USA. Molecular Subtypes of Breast Cancer. Luminal A: ER+ and or PR+ Her2 -ve Luminal B: ER+ and or PR + Her2+

766 views • 14 slides

BRCA1(Breast Cancer 1) and its relevance to familial breast cancer

BRCA1(Breast Cancer 1) and its relevance to familial breast cancer. Skyler Newhouse and Katherine Varley ( Camazine , 2011). Introduction. Gene: BRCA1 Mutation of BRCA1 increases chances of cancer by 35-85% Breast cancer is both genetic and non-genetic: Genetic risk factors:

434 views • 11 slides

1 Bear HD et al. Proc ASCO 2011;Abstract LBA1005.

213 views • 10 slides

Management of Triple-Negative Breast Cancer

Management of Triple-Negative Breast Cancer. Ismail Jatoi, MD, PhD, FACS Dale H. Dorn Chair in Surgery Professor and Chief, Division of Surgical Oncology University of Texas Health Science Center San Antonio, Texas. Three Treatment Options for Breast Cancer. Surgery Radiotherapy

1.19k views • 10 slides

Cameron D et al. Proc SABCS 2012;Abstract S6-5.

Primary Results of BEATRICE, a Randomized Phase III Trial Evaluating Adjuvant Bevacizumab-Containing Therapy in Triple-Negative Breast Cancer. Cameron D et al. Proc SABCS 2012;Abstract S6-5. Background.

237 views • 9 slides

Authors: Dr. Sunil Verma Date posted: June 22 nd , 2009

151 views • 6 slides